ESC 365 - Lignocaine versus opioids in coronary intervention: assessing antiplatelet activity and ticagrelor levels (LOCAL) Study

ESC Premium Access

Lignocaine versus opioids in coronary intervention: assessing antiplatelet activity and ticagrelor levels (LOCAL) Study

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Topic: Antiplatelet Drugs

Speaker: Doctor H. Fernando (Melbourne, AU)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Himawan Fernando

The Alfred Hospital, Melbourne (Australia)

0 follower

17 more presentations in this session

Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients with atrial fibrillation on direct-acting oral anticoagulants

Speaker: Mr A. Holt (Copenhagen, DK)

Usage and risk with phosphodiesterase type 5 inhibitors in male patients with chronic ischemic heart disease on oral organic nitrates

Speaker: Mr A. Holt (Copenhagen, DK)

PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual kinetic mechanism of action

Speaker: Mr Q. Ying (Perth, AU)

Antifibrotic and anti-inflammatory effects of the selective nonsteroidal MR antagonist finerenone in preclinical pulmonary fibrosis

Speaker: Doctor M. Delbeck (Wuppertal, DE)

Aspirin vs. P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation: insights from the AFIRE trial

Speaker: Assistant Professor H. Fukaya (Sagamihara, JP)

Access the full session

Congress committee e-posters choice in pharmacology and pharmacotherapy

Speakers: Doctor H. Fernando, Mr A. Holt, Mr A. Holt, Mr Q. Ying, Doctor M. Delbeck...

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

Mechanisms of myocardial injury and clinical outcomes in patients hospitalised with suspected COVID-19

29 August 2021

ESC Premium Access

ACTIVE-AF: A randomised controlled trial of exercise training in AF patients

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

ESC 365 is supported by